Metraipolis › archive › dc_b66679620b4e

The Inflation Reduction Act and Drug Development: Potential Early Signals of Impact on Post-Approval Clinical Trials — Europe PMC PMID:40261541

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40261541
DOI
10.1007/s43441-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-10-06T19:02:48.712Z
SHA-256 of the archived text
88362c4c04d71d921b7d734beb20565efb99f3ece1ab3251ee1a3e8e721c6583
Stable URL of this page
https://metraipolis.com/documento/dc_b66679620b4e

How to cite

The Inflation Reduction Act and Drug Development: Potential Early Signals of Impact on Post-Approval Clinical Trials — Europe PMC PMID:40261541 — Europe PMC (en), https://europepmc.org/article/MED/40261541 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b66679620b4e (Metraipolis archive dc_b66679620b4e, sha256 88362c4c04d71d921b7d734beb20565efb99f3ece1ab3251ee1a3e8e721c6583)
BibTeX
@misc{dcb66679620b4e,
  title = {The Inflation Reduction Act and Drug Development: Potential Early Signals of Impact on Post-Approval Clinical Trials — Europe PMC PMID:40261541},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40261541},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b66679620b4e; sha256 88362c4c04d71d921b7d734beb20565efb99f3ece1ab3251ee1a3e8e721c6583},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40261541. Agents can read the archived copy with the MCP tool read_document.